DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Acquired by UniSuper Management Pty Ltd

UniSuper Management Pty Ltd raised its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1,153.6% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 26,126 shares of the medical instruments supplier’s stock after purchasing an additional 24,042 shares during the period. UniSuper Management Pty Ltd’s holdings in DENTSPLY SIRONA were worth $867,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Norges Bank purchased a new stake in shares of DENTSPLY SIRONA during the fourth quarter valued at $114,207,000. Nuance Investments LLC grew its holdings in shares of DENTSPLY SIRONA by 30.4% during the fourth quarter. Nuance Investments LLC now owns 11,603,889 shares of the medical instruments supplier’s stock valued at $412,982,000 after buying an additional 2,702,457 shares during the last quarter. Generation Investment Management LLP grew its holdings in shares of DENTSPLY SIRONA by 43.4% during the fourth quarter. Generation Investment Management LLP now owns 6,598,211 shares of the medical instruments supplier’s stock valued at $234,830,000 after buying an additional 1,998,012 shares during the last quarter. Wellington Management Group LLP grew its holdings in shares of DENTSPLY SIRONA by 21.1% during the fourth quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier’s stock valued at $289,640,000 after buying an additional 1,419,503 shares during the last quarter. Finally, SG Americas Securities LLC grew its holdings in shares of DENTSPLY SIRONA by 2,959.1% during the first quarter. SG Americas Securities LLC now owns 1,373,421 shares of the medical instruments supplier’s stock valued at $45,584,000 after buying an additional 1,328,525 shares during the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on XRAY shares. Evercore ISI dropped their price objective on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, July 9th. The Goldman Sachs Group lowered their price target on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating on the stock in a report on Monday, May 6th. Needham & Company LLC lowered their price target on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating on the stock in a report on Friday, May 3rd. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 price target on shares of DENTSPLY SIRONA in a report on Monday, July 8th. Finally, Piper Sandler reaffirmed a “neutral” rating and issued a $32.00 price target (down from $35.00) on shares of DENTSPLY SIRONA in a report on Friday, May 3rd. Five equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, DENTSPLY SIRONA has a consensus rating of “Moderate Buy” and an average target price of $33.67.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock traded up $0.33 during trading hours on Thursday, reaching $26.57. The stock had a trading volume of 113,907 shares, compared to its average volume of 3,102,842. The stock’s 50 day moving average is $26.39 and its 200 day moving average is $30.52. The firm has a market capitalization of $5.52 billion, a PE ratio of -59.64, a PEG ratio of 1.17 and a beta of 1.01. DENTSPLY SIRONA Inc. has a twelve month low of $23.94 and a twelve month high of $41.65. The company has a current ratio of 1.43, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.42. The business had revenue of $953.00 million during the quarter, compared to the consensus estimate of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The company’s revenue was down 2.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.39 earnings per share. Equities analysts expect that DENTSPLY SIRONA Inc. will post 2.02 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, July 12th. Investors of record on Friday, June 28th were given a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, June 28th. This represents a $0.64 annualized dividend and a dividend yield of 2.41%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -145.45%.

Insider Buying and Selling

In related news, Director Gregory T. Lucier purchased 3,577 shares of DENTSPLY SIRONA stock in a transaction that occurred on Friday, May 31st. The stock was purchased at an average price of $27.95 per share, for a total transaction of $99,977.15. Following the transaction, the director now directly owns 58,374 shares in the company, valued at $1,631,553.30. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Insiders own 0.52% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.